Suelee Robbe-Austerman Diagnostics

42
Mycobacterial Diseases of Livestock Current techniques and advances in diagnostics for mycobacterial diseases (organism detection) Suelee Robbe-Austerman, DVM, PhD Mycobacteria Brucella Section Head National Veterinary Services Laboratories U.S. Department of Agriculture Animal and Plant Health Inspection Service Veterinary Services STAS 10/18/2014 Veterinary Services

Transcript of Suelee Robbe-Austerman Diagnostics

Page 1: Suelee Robbe-Austerman Diagnostics

Mycobacterial Diseases of Livestock

Current techniques and advances in

diagnostics for mycobacterial diseases

(organism detection)

Suelee Robbe-Austerman, DVM, PhD Mycobacteria Brucella Section Head

National Veterinary Services Laboratories

U.S. Department of Agriculture Animal and Plant Health Inspection Service

Veterinary Services STAS

10/18/2014

Veterinary Services

Page 2: Suelee Robbe-Austerman Diagnostics

Objectives- Mycobacterial organism detection assays

•  Brief history •  Advances in mycobacterial culture

techniques •  Advances in culture independent

techniques for detection/identification •  Advances in genotyping – WGS •  Future directions

2

Page 3: Suelee Robbe-Austerman Diagnostics

The turn of the century-1900

Page 4: Suelee Robbe-Austerman Diagnostics

The impact of cracking the DNA code

“Today clinical laboratories have to deal with more than 25 other mycobacterial species.”

LB Heifets, 1989 Current list (10/06/2014) standing nomenclature

– 169 species, 13 subspecies… Approx. 20 - 30% of mycobacteria isolated at

NVSL still appear to be unnamed.

Page 5: Suelee Robbe-Austerman Diagnostics

Bacterial culture of Mycobacteria

•  Challenges – Slow growing – Fastidious, some require specialized media,

temperatures or ingredients- pyruvate, mycobactin j, heme, etc…

– Many are non-culturable: M. leprae, mungi, cutaneous lesions.

•  Advances: Liquid culture systems

5

Page 6: Suelee Robbe-Austerman Diagnostics

Culture independent – Direct detection

•  Direct PCR

6

How to go from this To this!

Page 7: Suelee Robbe-Austerman Diagnostics

A new chapter in diagnostics •  PCR was developed ~1983, real time PCR in

the 1990’s.. Why is this a “new thing”? – Has been an adjunct test in the laboratory for a

long time. •  Significant decreases in costs. •  Significant improvements in extraction

protocols, especially difficult sample types. •  Significant improvements in chemistry. •  AAVLD currently developing guidelines

Page 8: Suelee Robbe-Austerman Diagnostics

Single PCR workflow? •  Tissue extraction •  Fecal/environmental extraction •  Culture extraction

•  Different primer/probe combinations that are optimized for the same Thermocycler settings

8

Page 9: Suelee Robbe-Austerman Diagnostics

9

Page 10: Suelee Robbe-Austerman Diagnostics

10

Page 11: Suelee Robbe-Austerman Diagnostics

11

Collec&on  Plate  

Spin  Column  Plate  

Deep  Well  Plate  

Page 12: Suelee Robbe-Austerman Diagnostics

12

Page 13: Suelee Robbe-Austerman Diagnostics

Building a PCR to manage error •  Tuberculosis – False positives and false

negatives both result in major consequences – Confirm a positive with a different target

•  Use Mtb-avirulent strain as positive control every 5-10 wells

•  Confirm with an M. bovis specific primer/probe •  Culture all positive (non-negative samples)

13

Page 14: Suelee Robbe-Austerman Diagnostics

14

Page 15: Suelee Robbe-Austerman Diagnostics

15

Page 16: Suelee Robbe-Austerman Diagnostics

16

21

22

23

24

25

26

27

28

29

30

31

32

33

34

35

36

37

38

39

40

0 20 40 60 80 100 120 140 160 180 200 220 240 260 280

Ct v

alue

Days

Scatter Plot of Positive Samples

False Positives

Positives

M. bovis Cont.

TB Cont.

Page 17: Suelee Robbe-Austerman Diagnostics

Johne’s fecal direct PCR •  Reference – positive sample

Page 18: Suelee Robbe-Austerman Diagnostics

NVSL MTBC Performance

18

Validation

Sensitivity = 96.61 % Specificity = 99.79 %

6 mo. in practice

Sensitivity = 100.00 % Specificity = 98.89 %

Page 19: Suelee Robbe-Austerman Diagnostics

Advances in genotyping •  Whole genome sequencing

19

Page 20: Suelee Robbe-Austerman Diagnostics

Workflow

Page 21: Suelee Robbe-Austerman Diagnostics

Reference Independent

Outputs from kSNP

Page 22: Suelee Robbe-Austerman Diagnostics

Reference Analysis

Page 23: Suelee Robbe-Austerman Diagnostics

Reference Analysis

Page 24: Suelee Robbe-Austerman Diagnostics

Alignment and VCF

•  Alignments are made using BWA

•  BAM files are processed using Genome Analysis Toolkit (GATK)’s “best practice” workflow including duplicate marking, local realignment and base quality recalibration.

•  SNPs are called using GATK’s UnifiedGenotyper outputting SNPs to variant call files (VCFs).

Page 25: Suelee Robbe-Austerman Diagnostics

25

(85 min for 24 isolates)

Script 1 output contains 3 sections

Page 26: Suelee Robbe-Austerman Diagnostics

26

Page 27: Suelee Robbe-Austerman Diagnostics

27

Page 28: Suelee Robbe-Austerman Diagnostics

VCF to FASTA

•  Use common Unix programs to output easy to interpret SNP comparisons from multiple VCFs as both SNP tables and fasta files to generate phylogenetic trees. –  VCF files are gathered from the

relevant database –  SNPs are filtered

•  QUAL scores (<300), Allele calls (AC=2)

•  Areas with unreliable alignment (<1%)

–  Defining SNP positions filter isolates into groups, subgroups and clades

Page 29: Suelee Robbe-Austerman Diagnostics

29

Script 2 output contains 3 sections

(95 min for 1200 VFC files)

Page 30: Suelee Robbe-Austerman Diagnostics

30

Page 31: Suelee Robbe-Austerman Diagnostics

SNP Verification

Page 32: Suelee Robbe-Austerman Diagnostics

32

Into Excel template for SNP table

Into Alignment program for Phylogenetic tree

Page 33: Suelee Robbe-Austerman Diagnostics

Future direction •  Sequence the Mycobacteria directly from

sample. – Host removal techniques need improvement

•  Taxonomy naming conventions for strains •  Database curation and validation of

isolates and sequences

33

Page 34: Suelee Robbe-Austerman Diagnostics

34

Total reads: 11712 Mapped reads: 11712 (100%) Forward strand: 5851 (49.9573%) Reverse strand: 5861 (50.0427%) Paired-end reads: 11712 (100%) Both pairs mapped: 11631 (99.3084%) Read 1: 5903 Read 2: 5809 Singletons: 81 (0.691598%) fastq file sizes: 3.1M 3.1M Unmapped fastq file sizes: 4.8K 4.9K Unmapped contig count: 8 Average coverage: 0.62975X Reference with coverage: 42.4536%

Quality metrics Sequencing directly from a granuloma with no host removal 1 MiSeq 500 cycle chip MBTC direct PCR of granuloma Ct= 22.3

Page 35: Suelee Robbe-Austerman Diagnostics

35

Page 36: Suelee Robbe-Austerman Diagnostics

36

Page 37: Suelee Robbe-Austerman Diagnostics

Future direction •  Sequence the Mycobacteria directly from

sample. – Host removal techniques need improvement

•  Taxonomy naming conventions for strains •  Database curation and validation of

isolates and sequences

37

Page 38: Suelee Robbe-Austerman Diagnostics

M. canetti

H37

R

Harlem

M. a

frica

num

? C

HPL

_A,

M. bovis

Page 39: Suelee Robbe-Austerman Diagnostics

Cervid group B

Cervid group A

Michigan

Molokai, HI

SB0673 Family

SB0120 Family

SB0130 Family

Group 8

Group 21

Group 11

Group 12 Gro

up 7

Gro

up 6

Gro

up 5

Group 20

Group 18

Group 9 Group 15

Group 17

MTBC

AF2122/97 Reference

Page 40: Suelee Robbe-Austerman Diagnostics

Future direction •  Sequence the Mycobacteria directly from

sample. – Host removal techniques need improvement

•  Taxonomy naming conventions for strains •  Database curation and validation of

isolates and sequences

40

Page 41: Suelee Robbe-Austerman Diagnostics

Pipeline Available

•  https://github.com/stuber/SNP_analysis

Page 42: Suelee Robbe-Austerman Diagnostics

Questions?